ALK and adenocarcinoma: This patient has diagnosed with stage IIIB adenocarcinoma without ALK translocation and EGFR mutation in the left lower lobe (Figure 6A), thus three cycles of neoadjuvant Toripalimab combined with chemotherapy were used for the surgical opportunity.